These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20432461)

  • 21. Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.
    Lund CV; Popkov M; Magnenat L; Barbas CF
    Mol Cell Biol; 2005 Oct; 25(20):9082-91. PubMed ID: 16199884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
    Bourguignon LY; Gilad E; Peyrollier K
    J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling.
    Vijapurkar U; Kim MS; Koland JG
    Exp Cell Res; 2003 Apr; 284(2):291-302. PubMed ID: 12651161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.
    Hong SH; Lee WJ; Kim YD; Kim H; Jeon YJ; Lim B; Cho DH; Heo WD; Yang DH; Kim CY; Yang HK; Yang JK; Jung YK
    Oncotarget; 2016 Apr; 7(16):21601-17. PubMed ID: 26942872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC; Miyake T; Parsons SJ
    Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
    Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H; Akita RW; Sliwkowski MX; Maihle NJ
    Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of integrin αvβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin.
    Yoshioka T; Nishikawa Y; Ito R; Kawamata M; Doi Y; Yamamoto Y; Yoshida M; Omori Y; Kotanagi H; Masuko T; Enomoto K
    Cancer Sci; 2010 Sep; 101(9):2011-8. PubMed ID: 20626753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
    Asp N; Pust S; Sandvig K
    Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis.
    Liberelle M; Magnez R; Thuru X; Bencheikh Y; Ravez S; Quenon C; Drucbert AS; Foulon C; Melnyk P; Van Seuningen I; Lebègue N
    Sci Rep; 2019 Nov; 9(1):16678. PubMed ID: 31723153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.
    Mizutani K; Kedashiro S; Maruoka M; Ueda Y; Takai Y
    Sci Rep; 2017 Sep; 7(1):11375. PubMed ID: 28900130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
    Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
    Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell signaling through membrane mucins.
    Carraway KL; Ramsauer VP; Haq B; Carothers Carraway CA
    Bioessays; 2003 Jan; 25(1):66-71. PubMed ID: 12508284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.
    Mukhopadhyay P; Lakshmanan I; Ponnusamy MP; Chakraborty S; Jain M; Pai P; Smith LM; Lele SM; Batra SK
    PLoS One; 2013; 8(2):e54455. PubMed ID: 23408941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.